Forum Financial Management LP Purchases Shares of 10,891 Fresenius Medical Care AG (NYSE:FMS)

Forum Financial Management LP purchased a new position in shares of Fresenius Medical Care AG (NYSE:FMS - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 10,891 shares of the company's stock, valued at approximately $247,000.

Several other hedge funds and other institutional investors have also bought and sold shares of FMS. Venturi Wealth Management LLC increased its position in shares of Fresenius Medical Care by 8.4% in the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock worth $129,000 after purchasing an additional 441 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of Fresenius Medical Care by 5.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 9,278 shares of the company's stock worth $210,000 after acquiring an additional 442 shares during the period. MML Investors Services LLC increased its stake in Fresenius Medical Care by 5.3% in the third quarter. MML Investors Services LLC now owns 15,019 shares of the company's stock valued at $320,000 after acquiring an additional 753 shares during the last quarter. Smartleaf Asset Management LLC raised its position in Fresenius Medical Care by 192.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock valued at $28,000 after purchasing an additional 806 shares in the last quarter. Finally, DAVENPORT & Co LLC lifted its stake in Fresenius Medical Care by 1.5% during the fourth quarter. DAVENPORT & Co LLC now owns 58,147 shares of the company's stock worth $1,316,000 after purchasing an additional 862 shares during the last quarter. Institutional investors and hedge funds own 8.37% of the company's stock.

Fresenius Medical Care Price Performance

FMS stock traded up $0.46 during midday trading on Monday, reaching $24.92. 87,351 shares of the stock were exchanged, compared to its average volume of 316,954. Fresenius Medical Care AG has a 52 week low of $17.93 and a 52 week high of $25.96. The company has a fifty day moving average price of $23.95 and a 200 day moving average price of $23.03. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The stock has a market capitalization of $14.62 billion, a PE ratio of 20.60, a P/E/G ratio of 0.76 and a beta of 0.93.

Analysts Set New Price Targets

FMS has been the subject of a number of research analyst reports. StockNews.com raised Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a report on Wednesday, February 5th. Truist Financial raised their price target on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the company a "hold" rating in a research note on Monday, January 6th.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.